Vukmir R B
Department of Anesthesiology/Critical Care and Emergency Medicine, University of Pittsburgh Medical Center, PA, USA.
Am J Emerg Med. 1995 Jul;13(4):459-70. doi: 10.1016/0735-6757(95)90139-6.
Cardiac dysfunction is often manifested as arrhythmia, with disruption of the normal periodicity and regularity of electromechanical activity. The therapy for arrhythmia begins with proper diagnosis, since many pharmacological interventions are themselves arrhythmogenic. Intervention for acute arrhythmia involves correction of underlying systemic conditions by ensuring adequate oxygenation, ventilation, acid-base homeostasis, electrolyte balance, and fluid status. Classification of antiarrhythmic agents assists in a structured treatment approach that utilizes different agents based on the etiology of the arrhythmia and the drug's mechanism of action. A deliberate treatment strategy guided by the morphological criteria of the arrhythmia modified by the rate and duration of complexes, noting symptoms and hemodynamic stability, is desirable.
心脏功能障碍常表现为心律失常,伴有正常机电活动的周期性和规律性破坏。心律失常的治疗始于正确诊断,因为许多药物干预本身就有致心律失常作用。急性心律失常的干预包括通过确保充足的氧合、通气、酸碱平衡、电解质平衡和液体状态来纠正潜在的全身状况。抗心律失常药物的分类有助于采用结构化的治疗方法,该方法根据心律失常的病因和药物的作用机制使用不同的药物。以心律失常的形态学标准为指导,结合复合波的速率和持续时间进行调整,并注意症状和血流动力学稳定性,制定一个深思熟虑的治疗策略是可取的。